TRPC6 up-regulation in Ang II-induced podocyte apoptosis might result from ERK activation and NF-κB translocation

Experimental Biology and Medicine

Volumn 234, Issue 9, 2009, Pages 1029-1036

  Zhang, Han ^a   Ding, Jie ^a   Fan, Qingfeng ^a   Liu, Shufang ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Angiotensin II; Calcium; ERK; NF B; Podocyte apoptosis; TRPC6

Indexed keywords

AMMONIA; ANGIOTENSIN II; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PYRROLIDINE DITHIOCARBAMATE; SMALL INTERFERING RNA; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; UO 126;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; GENE TRANSLOCATION; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PODOCYTE; PROTEIN EXPRESSION; UPREGULATION;

ANGIOTENSIN II; ANIMALS; APOPTOSIS; BUTADIENES; CALCIUM; CELL LINE; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MICE; NF-KAPPA B P50 SUBUNIT; NITRILES; PODOCYTES; PYRROLIDINES; THIOCARBAMATES; TRPC CATION CHANNELS; UP-REGULATION;

EID: 70349149065     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0901-RM-11     Document Type: Article

References (25)

1. Volpe M, Savoia C, De Paolis P, Ostrowska B, Tarasi D, Rubattu S. The renin-angiotensin system as a risk factor and therapeutic target for cardiovascular and renal disease. J Am Soc Nephrol 13 Suppl 3:S173-178, 2002. (Pubitemid 35216020)
2. Wolf G, Butzmann U, Wenzel UO. The renin-angiotensin system and progression of renal disease: from hemodynamics to cell biology. Nephron Physiol 93:3-13, 2003. (Pubitemid 37499910)
3. Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52:11-34, 2000. (Pubitemid 30127593)
4. Ding G, Reddy K, Kapasi AA, Franki N, Gibbons N, Kasinath BS, Singhal PC. Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal Physiol 283:F173-180, 2002. (Pubitemid 34680484)
5. Jia J, Ding G, Zhu J, Chen C, Liang W, Franki N, Singhal PC. Angiotensin II infusion induces nephrin expression changes and podocyte apoptosis. Am J Nephrol 28:500-507, 2008.
6. Durvasula RV, Shankland SJ. Podocyte injury and targeting therapy: an update. Curr Opin Nephrol Hypertens 15:1-7, 2006.
7. Barisoni L, Mundel P. Podocyte biology and the emerging understanding of podocyte diseases. Am J Nephrol 23:353-360, 2003. (Pubitemid 37116935)
8. Asanuma K, Mundel P. The role of podocytes in glomerular pathobiology. Clin Exp Nephrol 7:255-259, 2003.
9. Pavenstädt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 83:253-307, 2003.
10. Suzuki K, Han GD, Miyauchi N, Hashimoto T, Nakatsue T, Fujioka Y, Koike H, Shimizu F, Kawachi H. Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall. Am J Pathol 170:1841-1853, 2007.
11. Winn MP, Conlon PJ, Lynn KL, Farrington MK, Creazzo T, Hawkins AF, Daskalakis N, Kwan SY, Ebersviller S, Burchette JL, Pericak-Vance MA, Howell DN, Vance JM, Rosenberg PB. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308:1801-1804, 2005.
12. Gudermann T. A new TRP to kidney disease. Nat Genet 37:663-664, 2005.
13. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22:153-183, 2001. (Pubitemid 32458157)
14. Tian W, Zhang Z, Cohen DM. MAPK signaling and the kidney. Am J Physiol Renal Physiol 279:F593-604, 2000.
15. Martinka S, Bruggeman LA. Persistent NF-kappaB activation in renal epithelial cells in a mouse model of HIV-associated nephropathy. Am J Physiol Renal Physiol 290:F657-665, 2006. (Pubitemid 43724968)
16. Rípová D, Platilová V, Strunecká A, Jirák R, Höschl C. Alterations in calcium homeostasis as biological marker for mild Alzheimer's disease? Physiol Res 53(4):449-452, 2004.
17. Möller CC, Wei C, Altintas MM, Li J, Greka A, Ohse T, Pippin JW, Rastaldi MP, Wawersik S, Schiavi S, Henger A, Kretzler M, Shankland SJ, Reiser J. Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. J Am Soc Nephrol 18:29-36, 2007. (Pubitemid 46053419)
18. Kriz W. TRPC6 - a new podocyte gene involved in focal segmental glomerulosclerosis. Trends Mol Med 11:527-530, 2005. (Pubitemid 41713992)
19. Estacion M, Sinkins WG, Jones SW, Applegate MA, Schilling WP. Human TRPC6 expressed in HEK 293 cells forms non-selective cation channels with limited Ca2+ permeability. J Physiol 572:359-377, 2006.
20. Reiser J, Polu KR, Möller CC, Kenlan P, Altintas MM, Wei C, Faul C, Herbert S, Villegas I, Avila-Casado C, McGee M, Sugimoto H, Brown D, Kalluri R, Mundel P, Smith PL, Clapham DE, Pollak MR. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 37:739-744, 2005. (Pubitemid 41754891)
21. Shan D, Marchase RB, Chatham JC. Overexpression of TRPC3 increases apoptosis but not necrosis in response to ischemia-reperfusion in adult mouse cardiomyocytes. Am J Physiol Cell Physiol 294:C833-841, 2008.
22. Satoh S, Tanaka H, Ueda Y, Oyama J, Sugano M, Sumimoto H, Mori Y, Makino N. Transient receptor potential (TRP) protein 7 acts as a G protein-activated Ca2+ channel mediating angiotensin II-induced myocardial apoptosis. Mol Cell Biochem 294:205-215, 2007. (Pubitemid 46188902)
23. Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14:649-683, 1996. (Pubitemid 26130197)
24. Takahashi Y, Watanabe H, Murakami M, Ohba T, Radovanovic M, Ono K, Iijima T, Ito H. Involvement of transient receptor potential canonical 1 (TRPC1) in angiotensin II-induced vascular smooth muscle cell hypertrophy. Atherosclerosis 195:287-296, 2007. (Pubitemid 350087957)
25. Zhang L, Ma Y, Zhang J, Cheng J, Du J. A new cellular signaling mechanism for angiotensin II activation of NF-kappaB: an IkappaB-independent, RSK-mediated phosphorylation of p65. Arterioscler Thromb Vasc Biol 25:1148-1153, 2005.